About this FactMed analysis covering adverse side effect reports of KREMEZIN patients who developed REFLEXES ABNORMAL.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking KREMEZIN reported REFLEXES ABNORMAL to the FDA. A total of 441 KREMEZIN drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between KREMEZIN and REFLEXES ABNORMAL. In doing so, we compare KREMEZIN with other drugs that cause REFLEXES ABNORMAL, to help you evaluate whether or not KREMEZIN causes REFLEXES ABNORMAL. Likewise, this page shows the most highly-reported side effects of KREMEZIN, so you can see if REFLEXES ABNORMAL ranks among KREMEZIN's most well-known side effects.
Summary Statistics
Reports of KREMEZIN causing REFLEXES ABNORMAL: 2
Reports of any side effect of KREMEZIN : 441
Percentage of KREMEZIN patients where REFLEXES ABNORMAL is a reported side effect: 0.4535%

FDA reports of any drug causing REFLEXES ABNORMAL : 276
Average percentage for all medicated patients where REFLEXES ABNORMAL is reported as a complication: 0.0017%

Physician opinion on KREMEZIN as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing KREMEZIN:
RENAL FAILURE CHRONIC ( 62 patients )
RENAL FAILURE ( 19 patients )
AZOTAEMIA ( 17 patients )
RENAL IMPAIRMENT ( 9 patients )
PROPHYLAXIS ( 8 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 8 patients )
HYPERTENSION ( 6 patients )
DIABETIC NEPHROPATHY ( 6 patients )
DRUG USE FOR UNKNOWN INDICATION ( 5 patients )
SPINAL OSTEOARTHRITIS ( 3 patients )
DETOXIFICATION ( 3 patients )
IRON OVERLOAD ( 3 patients )
DIABETES MELLITUS ( 2 patients )
GLOMERULONEPHRITIS CHRONIC ( 2 patients )
NEPHROSCLEROSIS ( 2 patients )
HYPERLIPIDAEMIA ( 2 patients )
RENAL DISORDER ( 1 patients )
BLOOD POTASSIUM INCREASED ( 1 patients )
GASTROOESOPHAGEAL REFLUX DISEASE ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with REFLEXES ABNORMAL:

AMITRIPTYLINE HYDROCHLORIDE (24 patients)
TRITTICO (20 patients)
TYSABRI (18 patients)
AVONEX (16 patients)
VIOXX (16 patients)
LANSOPRAZOLE (14 patients)
FOSAMAX (13 patients)
ZYPREXA (13 patients)
LORAZEPAM (13 patients)
ALENDRONATE SODIUM (11 patients)
CYMBALTA (11 patients)
NEURONTIN (10 patients)
TRUXAL (10 patients)
PAXIL (10 patients)
SIMVASTATIN (10 patients)
LOSARTAN POTASSIUM (10 patients)
CYCLOSPORINE (10 patients)
METHOTREXATE (10 patients)
DIAZEPAM (10 patients)
LYRICA (9 patients)
AMLODIPINE (9 patients)
ASPIRIN (9 patients)
CARBAMAZEPINE (9 patients)
METHYLPREDNISOLONE (8 patients)
OMEPRAZOLE (8 patients)
GABAPENTIN (8 patients)
CLOZARIL (8 patients)
RISPERDAL (7 patients)
FAMVIR (7 patients)
PALIPERIDONE (7 patients)
RISPERIDONE (7 patients)
HUMIRA (7 patients)
IMITREX (7 patients)
LASIX (6 patients)
INSULIN (6 patients)
RISEDRONATE SODIUM (6 patients)
LAMIVUDINE (6 patients)
METRONIDAZOLE (6 patients)
TAMOXIFEN CITRATE (6 patients)
LIPITOR (6 patients)
MIRTAZAPINE (6 patients)
NEORAL (6 patients)
PREDNISONE TAB (6 patients)
VALPROIC ACID (6 patients)
LEPONEX (6 patients)
VALPROATE SODIUM (5 patients)
NORVASC (5 patients)
LAMICTAL (5 patients)
LISINOPRIL (5 patients)
FLUOXETINE (5 patients)
METFORMIN HCL (5 patients)
ALLOPURINOL (5 patients)
AMANTADINE HCL (5 patients)
AMBIEN (5 patients)
SYNTHROID (5 patients)
HYDROCODONE (HYDROCODONE) (5 patients)
BACLOFEN (5 patients)
OXYCODONE HCL (5 patients)
PARLODEL (5 patients)
CALCIUM CARBONATE (5 patients)
REBIF (5 patients)
FUROSEMIDE (5 patients)
TEGRETOL (5 patients)
CIPROFLOXACIN (5 patients)
LEVOTHYROXINE SODIUM (5 patients)
HALOPERIDOL (4 patients)
NEXIUM (4 patients)
PROPRANOLOL (4 patients)
ACETAMINOPHEN (4 patients)
ORAL ANTIDIABETICS () (4 patients)
TACROLIMUS (4 patients)
PLAVIX (4 patients)
TRAMADOL HCL (4 patients)
ALPRAZOLAM (4 patients)
DOXORUBICIN HCL (4 patients)
AMLODIPINE BESYLATE (4 patients)
AMOXICILLIN AND CLAVULANATE POTASSIUM (4 patients)
OXYCONTIN (4 patients)
METOPROLOL TARTRATE (4 patients)
ANTIDEPRESSANTS () (4 patients)
ANTIEPILEPTICS () (4 patients)
ANTIHISTAMINES FOR SYSTEMIC USE () (4 patients)
PROZAC (4 patients)
ANTIPSYCHOTICS () (4 patients)
HYDROMORPHONE HCL (4 patients)
HUMALOG (4 patients)
DULCOLAX (4 patients)
LANTUS (4 patients)
LACTULOSE (4 patients)
AZATHIOPRINE (4 patients)
BENZODIAZEPINE DERIVATIVES() (4 patients)
OTHER TYPE OF GASTROINTESTINAL PREPARATION () (4 patients)
PREDNISONE (4 patients)
ETOPOSIDE (4 patients)
PREDNISOLONE (4 patients)
EFFEXOR (4 patients)
PRISTIQ (4 patients)
CARBOPLATIN (4 patients)
TEGRETOL-XR (4 patients)
FUCIDINE CAP (4 patients)
SENOKOT (4 patients)
FLUDARABINE PHOSPHATE (4 patients)
ZOLOFT (4 patients)
ZOLPIDEM TARTRATE (4 patients)
WELLBUTRIN (4 patients)
CLONAZEPAM (4 patients)
VENLAFAXINE HCL (4 patients)
LEXAPRO (4 patients)
METHADONE HYDROCHLORIDE (4 patients)
CYCLOPHOSPHAMIDE (4 patients)
DECONGESTANTS AND ANTIALLERGICS () (4 patients)
DIAMICRON (4 patients)
DIGOXIN (4 patients)
OROXINE (3 patients)
ABACAVIR (3 patients)
FLAGYL (3 patients)
ACETYLSALICYLIC ACID SRT (3 patients)
ADANCOR (3 patients)
PAXIL CR (3 patients)
OLANZAPINE (3 patients)
ALFAROL (3 patients)
ALTACE (3 patients)
LIORESAL (3 patients)
AMITRIPTYLINE HCL (3 patients)
PAROXETINE HCL (3 patients)
ANTIDIABETICS (3 patients)
FLUOXETINE HCL (3 patients)
LEVOMEPROMAZINE (3 patients)
VICODIN (3 patients)
VALTURNA (3 patients)
VITAMIN D (3 patients)
DOXEPIN HCL (3 patients)
BACTRIM (3 patients)
MUCOSTA (3 patients)
NEXAVAR (3 patients)
BLINDED CGS 20267 T30748+ (3 patients)
BLINDED NO TREATMENT RECEIVED NOMED (3 patients)
BLINDED PLACEBO PLACEBO (3 patients)
PRAVASTATIN (3 patients)
FLEXERIL (3 patients)
PROCRIT /00928302/ (3 patients)
PREVACID (3 patients)
SYNTOCINON (3 patients)
SUSTIVA (3 patients)
SAQUINAVIR (3 patients)
GLIBENCLAMIDE (3 patients)
HYDROCHLOROTHIAZIDE (3 patients)
HYDROCORTISONE (3 patients)
THIOTEPA (3 patients)
XANAX (3 patients)
ZIDOVUDINE (3 patients)
CIPROFLOXACIN HCL (3 patients)
CITALOPRAM HYDROBROMIDE (3 patients)
LOXONIN (3 patients)
PRAVACHOL (3 patients)
COUMADIN (3 patients)
COZAAR (3 patients)
CYTARABINE (3 patients)
DEPAKENE (3 patients)
METHYCOBAL (3 patients)
DEROXAT (3 patients)
MYSOLINE (3 patients)
DEXAMETHASONE TAB (3 patients)
MYCOPHENOLATE MOFETIL (3 patients)
METOCLOPRAMIDE (2 patients)
PARACETAMOL (2 patients)
ACTONEL (2 patients)
ADVAIR DISKUS 100/50 (2 patients)
NITRIC OXIDE (2 patients)
MELOXICAM (2 patients)
AMOXICILLIN (2 patients)
OFLOXACIN (2 patients)
AMSACRINE (2 patients)
ANALGESIA (2 patients)
ANALGESIC() (2 patients)
ANPLAG (2 patients)
LODALES (2 patients)
MAVIK (2 patients)
LUPRON (2 patients)
METHYLERGOMETRINE MALEATE (2 patients)
MOTRIN (2 patients)
MORPHINE (2 patients)
NORTRIPTYLINE HCL (2 patients)
NOVOLOG (2 patients)
BETAFERON (2 patients)
NORVIR (2 patients)
NITROGLYCERIN (2 patients)
NAMENDA (2 patients)
MULTI-VITAMIN (2 patients)
ORAMORPH SR (2 patients)
NYSTATIN (2 patients)
BISACODYL (2 patients)
PANTOPRAZOLE (2 patients)
BLOPRESS (2 patients)
NUBAIN (2 patients)
CALBLOCK (2 patients)
MOVIPREP (2 patients)
CALCIUM CITRATE (2 patients)
LIDOCAINE (2 patients)
LORTAB (2 patients)
COLACE (2 patients)
MELPHALAN (2 patients)
MEGACE (2 patients)
COPAXONE (2 patients)
ZYVOX (2 patients)
LOTENSIN (2 patients)
MORPHINE SULFATE (2 patients)
CRESTOR (2 patients)
DECADRON (2 patients)
MIANSERIN (2 patients)
Most common side effects for patients taking KREMEZIN:
BLOOD CREATININE INCREASED (69 patients)
RENAL IMPAIRMENT (51 patients)
BLOOD UREA INCREASED (44 patients)
RENAL FAILURE CHRONIC (37 patients)
RENAL FAILURE (32 patients)
HYPERKALAEMIA (27 patients)
CARDIAC FAILURE (26 patients)
RENAL FAILURE ACUTE (26 patients)
RHABDOMYOLYSIS (25 patients)
ANAEMIA (21 patients)
NAUSEA (21 patients)
PYREXIA (19 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (17 patients)
EOSINOPHIL COUNT INCREASED (16 patients)
URINARY TRACT INFECTION (16 patients)
HYPERURICAEMIA (16 patients)
OEDEMA (15 patients)
HYPERGLYCAEMIA (15 patients)
CARDIAC FAILURE CONGESTIVE (14 patients)
CEREBRAL HAEMORRHAGE (14 patients)
DIARRHOEA (14 patients)
HYPERTENSION (14 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (13 patients)
ASTHENIA (13 patients)
PNEUMONIA (13 patients)
C-REACTIVE PROTEIN INCREASED (13 patients)
CEREBRAL INFARCTION (13 patients)
PLATELET COUNT DECREASED (13 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (13 patients)
HAEMODIALYSIS (13 patients)
INTERSTITIAL LUNG DISEASE (13 patients)
VOMITING (12 patients)
DECREASED APPETITE (12 patients)
HAEMOGLOBIN DECREASED (12 patients)
BLOOD PRESSURE DECREASED (11 patients)
BLOOD PRESSURE INCREASED (11 patients)
DIALYSIS (11 patients)
MALAISE (11 patients)
GAIT DISTURBANCE (11 patients)
CONDITION AGGRAVATED (10 patients)
THROMBOCYTOPENIA (10 patients)
ALANINE AMINOTRANSFERASE INCREASED (9 patients)
ALTERED STATE OF CONSCIOUSNESS (9 patients)
MYOGLOBINURIA (9 patients)
DEHYDRATION (9 patients)
DRUG INTERACTION (9 patients)
MYALGIA (9 patients)
HYPOGLYCAEMIA (9 patients)
PULMONARY OEDEMA (8 patients)
WHITE BLOOD CELL COUNT DECREASED (8 patients)
BLOOD CREATINE INCREASED (8 patients)
BLOOD POTASSIUM DECREASED (8 patients)
BLOOD POTASSIUM INCREASED (8 patients)
MYOCLONUS (8 patients)
PLEURAL EFFUSION (8 patients)
PROSTATE CANCER (8 patients)
DYSKINESIA (8 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (8 patients)
TRANSIENT ISCHAEMIC ATTACK (8 patients)
NEPHROGENIC ANAEMIA (7 patients)
ANGINA PECTORIS (7 patients)
ANOREXIA (7 patients)
PNEUMONIA ASPIRATION (7 patients)
ATRIAL FLUTTER (7 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (7 patients)
CARDIAC FAILURE CHRONIC (7 patients)
CONVULSION (7 patients)
RENAL DISORDER (7 patients)
DIABETIC NEPHROPATHY (7 patients)
PYELONEPHRITIS (7 patients)
ECZEMA (7 patients)
STEVENS-JOHNSON SYNDROME (7 patients)
GASTRIC ULCER HAEMORRHAGE (7 patients)
GASTROINTESTINAL HAEMORRHAGE (7 patients)
MYOCARDIAL INFARCTION (7 patients)
HEPATIC FUNCTION ABNORMAL (7 patients)
RASH (6 patients)
ASCITES (6 patients)
VENTRICULAR FIBRILLATION (6 patients)
BLOOD BILIRUBIN INCREASED (6 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (6 patients)
LIVER DISORDER (6 patients)
CARDIAC ARREST (6 patients)
COLOUR BLINDNESS (6 patients)
PERITONITIS (6 patients)
TOXIC EPIDERMAL NECROLYSIS (6 patients)
WEIGHT INCREASED (6 patients)
MENTAL DISORDER (5 patients)
RED BLOOD CELL COUNT DECREASED (5 patients)
RECTAL PERFORATION (5 patients)
RESPIRATORY ARREST (5 patients)
BEDRIDDEN (5 patients)
LOSS OF CONSCIOUSNESS (5 patients)
SHOCK (5 patients)
LIPASE INCREASED (5 patients)
PULMONARY CONGESTION (5 patients)
DEATH (5 patients)
DYSARTHRIA (5 patients)
SPEECH DISORDER (5 patients)
FALL (5 patients)
FATIGUE (5 patients)
OESOPHAGEAL ULCER (5 patients)
HYPERCALCAEMIA (5 patients)
RESPIRATORY FAILURE (5 patients)
HYPONATRAEMIA (5 patients)
OVERDOSE (5 patients)
ABDOMINAL PAIN (4 patients)
LYMPHOPENIA (4 patients)
AGITATION (4 patients)
URINARY RETENTION (4 patients)
LUNG INFILTRATION (4 patients)
BLOOD GLUCOSE INCREASED (4 patients)
BRADYCARDIA (4 patients)
CARDIO-RESPIRATORY ARREST (4 patients)
CHEST PAIN (4 patients)
DIABETIC KETOACIDOSIS (4 patients)
DIABETIC NEUROPATHY (4 patients)
DIASTOLIC DYSFUNCTION (4 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (4 patients)
DRUG ERUPTION (4 patients)
LARGE INTESTINAL OBSTRUCTION (4 patients)
MELAENA (4 patients)
FEBRILE NEUTROPENIA (4 patients)
FEMUR FRACTURE (4 patients)
NEUTROPHIL COUNT DECREASED (4 patients)
GRANULOCYTOPENIA (4 patients)
HAEMORRHAGIC DIATHESIS (4 patients)
NEPHROSCLEROSIS (4 patients)
HYPERPHOSPHATASAEMIA (4 patients)
PO2 ABNORMAL (4 patients)
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME (4 patients)
HYPOCALCAEMIA (4 patients)
ABASIA (3 patients)
ABDOMINAL DISTENSION (3 patients)
ABNORMAL BEHAVIOUR (3 patients)
PULMONARY HAEMORRHAGE (3 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
AGRANULOCYTOSIS (3 patients)
ANAEMIA MACROCYTIC (3 patients)
ANAPHYLACTIC SHOCK (3 patients)
ANTI-INSULIN ANTIBODY INCREASED (3 patients)
ASTERIXIS (3 patients)
BENIGN PROSTATIC HYPERPLASIA (3 patients)
BLOOD ALBUMIN DECREASED (3 patients)
BLOOD CHOLESTEROL INCREASED (3 patients)
BLOOD PRESSURE SYSTOLIC INCREASED (3 patients)
MANIA (3 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (3 patients)
CARDIAC FAILURE ACUTE (3 patients)
OEDEMA PERIPHERAL (3 patients)
CARDIOVASCULAR DISORDER (3 patients)
TUBULOINTERSTITIAL NEPHRITIS (3 patients)
CHOLELITHIASIS (3 patients)
URINE OUTPUT DECREASED (3 patients)
COMMUNICATION DISORDER (3 patients)
CONFUSIONAL STATE (3 patients)
CONSTIPATION (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DYSPNOEA (3 patients)
RESTLESSNESS (3 patients)
SUDDEN CARDIAC DEATH (3 patients)
ENCEPHALOPATHY (3 patients)
LOGORRHOEA (3 patients)
EOSINOPHILIA (3 patients)
SEROTONIN SYNDROME (3 patients)
RHINITIS ALLERGIC (3 patients)
EYELID OEDEMA (3 patients)
FAECAL INCONTINENCE (3 patients)
FEELING ABNORMAL (3 patients)
FLUID RETENTION (3 patients)
TOOTHACHE (3 patients)
GASTRITIS (3 patients)
TOXIC SKIN ERUPTION (3 patients)
MYOCARDIAL ISCHAEMIA (3 patients)
GLUCOSE TOLERANCE IMPAIRED (3 patients)
TREMOR (3 patients)
HAEMATOCRIT DECREASED (3 patients)
HAEMATURIA (3 patients)
URINARY INCONTINENCE (3 patients)
VASCULITIS (3 patients)
HICCUPS (3 patients)
HYPERBILIRUBINAEMIA (3 patients)
HYPOAESTHESIA (3 patients)
PROTEINURIA (3 patients)
INFECTION (3 patients)
INSOMNIA (3 patients)
ACIDOSIS (2 patients)
AKATHISIA (2 patients)
ANTI-INSULIN ANTIBODY POSITIVE (2 patients)
ANXIETY (2 patients)
APLASIA PURE RED CELL (2 patients)
BLOOD CREATINE PHOSPHOKINASE MB (2 patients)
BLOOD PRESSURE DIASTOLIC DECREASED (2 patients)
BLOOD PRESSURE FLUCTUATION (2 patients)
BLOOD PRESSURE INADEQUATELY CONTROLLED (2 patients)
DEPRESSED MOOD (2 patients)
RASH GENERALISED (2 patients)
DIABETES MELLITUS INADEQUATE CONTROL (2 patients)
DISEASE PROGRESSION (2 patients)
DIZZINESS (2 patients)
DRUG DOSE OMISSION (2 patients)
ELECTROCARDIOGRAM QT PROLONGED (2 patients)
HYPOCHLORAEMIA (2 patients)
PRURITUS (2 patients)
HYPOKALAEMIA (2 patients)
HYPOPHAGIA (2 patients)
HYPOPHOSPHATAEMIA (2 patients)
HYPOTHYROIDISM (2 patients)
HYPOTONIA (2 patients)
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION (2 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for KREMEZIN


Issue Description / Topic Timestamp
QUESTION
RENAL FAILURE ACUTE
Kremezin can be diagnose for chronic glomerulonephritis? 2015-07-03 05:28:23
QUESTION
RENAL FAILURE ACUTE
What is the kremizin side effect for patient takin it. 2015-11-14 21:30:41

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about REFLEXES ABNORMAL and KREMEZIN, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking KREMEZIN, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in KREMEZIN. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for KREMEZIN experts. If you are a healthcare provider experienced in prescribing KREMEZIN, please register here.
© 2014 FactMed, Inc
Privacy Policy
Terms of Use